Who owns CULLINAN ONCOLOGY INC?
- Ticker: CGEM
- CUSIP Number: 230031106
Tip: Access positions for across all investors
Analyze quarterly positions in Cullinan Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cullinan Oncology stock
Who bought or sold CULLINAN ONCOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Blue Owl Capital Holdings | 3.4M | $35M | 100% | Dec 2023 |
|
| Franklin Resources | 3.3M | $33M | 14% | Dec 2023 |
|
| BVF | 3.2M | $33M | 0% | Dec 2023 |
|
| Vanguard Group | 1.8M | $18M | 5% | Dec 2023 |
|
| Braidwell | 1.2M | $13M | -35% | Dec 2023 |
|
| American International | 1.2M | $13M | 0% | Dec 2023 |
|
| Nextech Invest | 1.2M | $12M | 0% | Dec 2023 |
|
| Citadel Advisors | 1.1M | $12M | 7% | Dec 2023 |
|
| Dimensional Fund Advisors | 916k | $9.3M | 15% | Dec 2023 |
|
| Tang Capital Management | 771k | $7.9M | 24% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 546k | $5.6M | 11717% | Dec 2023 |
|
| OrbiMed Advisors | 545k | $5.6M | 0% | Dec 2023 |
|
| Charles Schwab Investment Management | 247k | $2.5M | 7% | Dec 2023 |
|
| Millennium Management | 233k | $2.4M | -3% | Dec 2023 |
|
| Hudson Bay Capital Management | 225k | $2.3M | 0% | Dec 2023 |
|
| Kennedy Capital Management | 160k | $1.6M | -67% | Dec 2023 |
|
| Schonfeld Strategic Advisors | 141k | $1.4M | 16% | Dec 2023 |
|
| UBS Group | 141k | $1.4M | 36% | Dec 2023 |
|
| Bank of America Corporation | 135k | $1.4M | 31% | Dec 2023 |
|
| Goldman Sachs Group | 128k | $1.3M | 49% | Dec 2023 |
|
| DAFNA Capital Management | 127k | $1.3M | 0% | Dec 2023 |
|
| Bank of New York Mellon | 99k | $1.0M | 2% | Dec 2023 |
|
| Barclays | 85k | $867k | 60% | Dec 2023 |
|
| Cubist Systematic Strategies | 57k | $580k | 74% | Dec 2023 |
|
| Two Sigma Investments | 50k | $513k | 100% | Dec 2023 |
|
| D. E. Shaw & Co | 49k | $499k | 23% | Dec 2023 |
|
| Swiss National Bank | 46k | $472k | 20% | Dec 2023 |
|
| Rhumbline Advisers | 46k | $466k | 1% | Dec 2023 |
|
| Alliancebernstein | 43k | $442k | -1% | Dec 2023 |
|
| Credit Suisse | 43k | $437k | 120% | Dec 2023 |
|
| Martingale Asset Management | 43k | $433k | 0% | Dec 2023 |
|
| Algert Coldiron Investors | 41k | $418k | 148% | Dec 2023 |
|
| Two Sigma Advisers | 39k | $393k | 100% | Dec 2023 |
|
| Trexquant Investment | 35k | $356k | 100% | Dec 2023 |
|
| New York Life Investment Management | 34k | $344k | -3% | Dec 2023 |
|
| Marshall Wace | 33k | $340k | 100% | Dec 2023 |
|
| Jpmorgan Chase & Co | 25k | $257k | 4% | Dec 2023 |
|
| T. Rowe Price Associates | 22k | $225k | 53% | Dec 2023 |
|
| Hsbc Holdings | 22k | $221k | 0% | Dec 2023 |
|
| Commonwealth Equity Services | 21k | $214k | 0% | Dec 2023 |
|
| Squarepoint Ops | 20k | $205k | 100% | Dec 2023 |
|
| CornerCap Investment Counsel | 19k | $191k | 1% | Dec 2023 |
|
| Quest Partners | 18k | $179k | 100% | Dec 2023 |
|
| Exchange Traded Concepts | 17k | $287k | 20% | Mar 2024 |
|
| Harbor Capital Advisors | 15k | $147k | 41% | Dec 2023 |
|
| SG Americas Securities | 14k | $147k | 12% | Dec 2023 |
|
| Mirae Asset Global Investments | 14k | $144k | 0% | Dec 2023 |
|
| Legal & General Group | 14k | $143k | 0% | Dec 2023 |
|
| Jane Street | 14k | $141k | -17% | Dec 2023 |
|
| MetLife Investment Advisors | 13k | $136k | 0% | Dec 2023 |
|
| Annandale Capital | 12k | $122k | 0% | Dec 2023 |
|
| Virtus ETF Advisers | 11k | $111k | 29% | Dec 2023 |
|
| Bailard | 11k | $110k | 100% | Dec 2023 |
|
| Principal Financial Group | 11k | $109k | -2% | Dec 2023 |
|
| Citigroup | 11k | $108k | -55% | Dec 2023 |
|
| GSA Capital Partners | 10k | $104k | 100% | Dec 2023 |
|
| Vontobel Holding | 10k | $102k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 8.9k | $92k | -9% | Dec 2023 |
|
| Wells Fargo & Company | 8.0k | $82k | 35% | Dec 2023 |
|
| New York State Common Retirement Fund | 6.7k | $68k | -1% | Dec 2023 |
|
| Zurcher Kantonalbank | 6.5k | $67k | 0% | Dec 2023 |
|
| China Universal Asset Management | 5.0k | $50k | 352% | Dec 2023 |
|
| Point72 Asia | 2.9k | $29k | 100% | Dec 2023 |
|
| Russell Investments | 2.3k | $23k | 100% | Dec 2023 |
|
| Summit Investment Advisors | 2.0k | $20k | 0% | Dec 2023 |
|
| Parallel Advisors | 1.3k | $13k | 100% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 1.3k | $13k | 0% | Dec 2023 |
|
| Point72 Middle East FZE | 1.2k | $12k | -83% | Dec 2023 |
|
| Amalgamated Bank | 896.00 | $15k | -59% | Mar 2024 |
|
| Signature | 858.00 | $8.7k | 42% | Dec 2023 |
|
| Simplex Trading | 511.00 | $5.0k | -51% | Dec 2023 |
|
| Us Bancorp | 504.00 | $5.1k | 100% | Dec 2023 |
|
| GAMMA Investing | 496.00 | $8.5k | 20% | Mar 2024 |
|
| Lindbrook Capital | 291.00 | $3.0k | 100% | Dec 2023 |
|
| Quadrant Capital | 241.00 | $2.5k | 100% | Dec 2023 |
|
| Washington Trust Advisors | 127.00 | $1.3k | 0% | Dec 2023 |
|
| Daiwa Securities Group | 127.00 | $999.998000 | 0% | Dec 2023 |
|
| NISA Investment Advisors | 117.00 | $1.2k | -17% | Dec 2023 |
|
| Massmutual Trust | 36.00 | $613.000800 | 0% | Mar 2024 |
|
| CWM | 33.00 | $999.999000 | 14% | Mar 2024 |
|
| Pnc Financial Services | 17.00 | $173.000500 | 6% | Dec 2023 |
|
Who sold out of Cullinan Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Boxer Capital | Sep 2023 | 1.1M | $9.7M |
| AQR Capital Management | Sep 2023 | 22k | $197k |
| Federated Investors | Sep 2023 | 20k | $181k |
| State of Wisconsin Investment Board | Sep 2023 | 15k | $138k |
| Point72 Asset Management | Sep 2023 | 224.00 | $2.0k |
| Covestor | Sep 2023 | 123.00 | $1.0k |
| Baker Avenue Asset Management | Sep 2023 | 48.00 | $434.001600 |